Stay up to date on research and information
Sign Up for FORCE NewslettersPress Releases
Since 1999, FORCE has been the voice of experience for the hereditary cancer community and has emerged as a thought leader in this area.
FORCE in the News | FORCE Press Releases
April 03, 2023
Advocates for individuals in need of breast reconstructive surgery delivered a letter of petition to the Centers for Medicare and Medicaid Services (CMS) urging them to reinstate a procedure code that is essential for access to DIEP flap breast reconstruction surgery.
December 14, 2022
Wasserman Schultz, Klobuchar, Cardin, Fitzpatrick and DeSaulnier Lead Cancer Survivorship Bill
The Comprehensive Cancer Survivorship Act (CCSA) will address gaps in survivorship care and develop desperately needed standards to improve the overall patient-centered quality of care and navigation needs of cancer survivors and their families.
October 26, 2022
FORCE Elects New President and Member to its Board of Directors
FORCE is pleased to announce the election of Wenora Johnson as President and Sherri Silver to its board of directors.
October 11, 2022
FORCE Experts Write Breakthrough Book on Hereditary Cancer
Published by Johns Hopkins University Press, "Living with Hereditary Cancer Risk" is today's most definitive guide on hereditary cancer.
July 27, 2022
The National Comprehensive Cancer Network® (NCCN®) has published new NCCN Guidelines for breast cancer screening and diagnosis to help people understand their personal risk for breast cancer, when they should begin screening, and how often to screen.
March 30, 2022
Meagan Good joins Eisai, FORCE, SHARE and Black Health Matters as part of the Spot Her campaign to increase awareness and empower women to be outspoken about endometrial cancer.
March 24, 2022
FORCE Creates Online Tool to Combat Misleading Health News
FORCE has created an interactive toolkit and quiz designed to help people distinguish misleading health information from reliable health information online.
February 17, 2022
Bipartisan legislation has been introduced that would remedy a longstanding Medicare gap, ensuring that beneficiaries at increased risk of cancer have access to standard-of-care genetic counseling, testing, screening, and risk-reducing interventions.
December 07, 2021
Rapid advances in biomarker research improve outcomes for people with cancer. National Comprehensive Cancer Network Patient Advocacy Summit looks at policy and practice solutions to increase equitable access for all.
November 30, 2021
FORCE welcomes each of these individuals who bring unique skills and experiences along with diverse healthcare and advocacy backgrounds to FORCE.
June 23, 2021
FORCE Elects New Secretary to its Board of Directors
FORCE is pleased to announce that Carmen Pace has joined its board of directors as Secretary.
June 23, 2021
Wasserman Schultz Introduces Bipartisan Genetic Cancer Testing Access Expansion
The Reducing Hereditary Cancer Act is supported by FORCE, National Comprehensive Cancer Network (NCCN) and American Society of Clinical Oncology (ASCO), and would ensure Medicare beneficiaries can access genetic testing for cancer risk and take advantage of medically necessary, guideline-recommended screening and risk reducing interventions.
March 31, 2021
FORCE, together with Eisai, SHARE Cancer Support and Black Health Matters, launched the Spot Her Campaign to raise awareness of endometrial cancer, one of the two most common cancers associated with Lynch syndrome.
January 26, 2021
FORCE Elects New President and Secretary to its Board of Directors
FORCE is proud to announce that Carrie Catlin has been elected to the board of directors as President and Tammy Li has been elected as Secretary.
November 16, 2020
FORCE Elects Denise Bulpitt, Dana Goldman, Wenora Johnson and Carmen Pace to its Board of Directors
Four survivors of hereditary cancers bring unique skills and experiences to FORCE.
October 01, 2020
FORCE Expands to Provide Support for Anyone Impacted by Hereditary Cancer
FORCE has expanded and rebranded in an effort to better reflect its support for all individuals and families facing hereditary breast, colorectal, endometrial, ovarian, pancreatic and prostate cancers.
October 29, 2019
The CDC has awarded FORCE, together with Susan G. Komen ® and the University of South Florida, a five-year grant to provide credible, evidence-based information and services to young women with breast cancer.
August 09, 2019
Teri Woodhull’s career background and roles in numerous ovarian cancer organizations, as well as her passion for advocacy, make her the perfect new board president. Tara Freundlich has been an active member of FORCE since 2002, working as a volunteer and later as a board member. Her appointment as the new board vice president will serve the community well.
February 13, 2019
FORCE Elects Tammy Li to its Board of Directors
FORCE elects Tammy Li to its Board of Directors as Secretary. Tammy has 29 years of marketing and consulting experience, three years of FORCE volunteer experience and a personal connection to our community. Tammy is a valued addition to the Board.
January 01, 2019
FORCE Elects Debbie Setuain to its Board of Directors
FORCE elects Debbie Setuain to its Board of Directors as Treasurer. Debbie’s more than 25 years of accounting, finance and auditing experience, as well as her more than 6 year commitment to FORCE, make her a valuable addition to the Board
August 01, 2018
FORCE Announces 2018 Spirit of Empowerment Award Recipients
FORCE will present the 2018 Spirit of Empowerment Awards at the 11th annual Joining FORCEs Conference in San Diego, California on October 20, 2018. These awards acknowledge leaders in our community who, in collaboration with FORCE, have created change and made significant contributions to research, advocacy, clinical care, education, awareness and/or support of those impacted by hereditary cancer.
June 01, 2018
FORCE Announces 11th Annual Joining FORCEs Against Hereditary Cancer ® Conference
The Joining FORCEs Conference, the largest gathering for the hereditary cancer community, will be held for the first time on the west coast in San Diego, CA October 18-20, 2018. The conference is for anyone concerned about hereditary cancer: survivors, previvors, people with a genetic mutation or family history of cancer, patient advocates, researchers and health care providers who treat high-risk patients. The conference program will provide the opportunity to learn from leading experts, enroll in research and connect with others with similar experiences.
Media Contact
Karen Kramer
Senior Vice President, Marketing
301-509-4155
[email protected]
